Ascione R, Lloyd C T, Gomes W J, Caputo M, Bryan A J, Angelini G D
Bristol Heart Institute, Bristol Royal infirmary, UK.
Eur J Cardiothorac Surg. 1999 May;15(5):685-90. doi: 10.1016/s1010-7940(99)00072-x.
Conventional coronary artery bypass grafting (CABG) is both safe and effective. Nevertheless, the use of cardiopulmonary bypass (CPB) and cardioplegic arrest are associated with several adverse effects. Over the last 2 years there has been a revival of interest in performing CABG on the beating heart. In this prospective randomized study we evaluated the efficacy and safety of on and off pump coronary revascularization on myocardial function.
Eighty patients (65 males, mean age 61+/-9.7 years) undergoing first time CABG were prospectively randomized to: (i) conventional revascularization with CPB at normothermia and cardioplegic arrest with intermittent warm blood cardioplegia (on pump) or (ii) beating heart revascularization (off pump). Troponin I (Tn I) release was serially measured as a specific marker of myocardial damage. Haemodynamic measurements as well as inotropic requirement, incidence of arrhythmia and postoperative myocardial infarction were also recorded.
There were no significant differences between the two groups in terms of age, sex, extent of disease, left ventricular function and number of grafts. There were no deaths or intraoperative myocardial infarctions in either group. Tn I release was constantly lower in the off pump group and this was significant at 1, 4, 12 and 24 h postoperatively. Furthermore, in this group there was a significantly reduced incidence of arrhythmias. Inotropic requirements were less in the off pump group but this did not reach statistical significance.
These results suggest that off pump coronary revascularization is a safe and effective strategy for myocardial revascularization. Myocardial injury as assessed by Tn I release is also reduced when compared with conventional coronary revascularization with CPB and cardioplegic arrest.
传统冠状动脉旁路移植术(CABG)既安全又有效。然而,体外循环(CPB)和心脏停搏的使用会带来一些不良反应。在过去两年中,人们对在跳动心脏上进行CABG的兴趣再度兴起。在这项前瞻性随机研究中,我们评估了非体外循环和体外循环冠状动脉血运重建对心肌功能的疗效和安全性。
80例首次接受CABG的患者(65例男性,平均年龄61±9.7岁)被前瞻性随机分为:(i)在常温下使用CPB并采用间歇性温血心脏停搏进行传统血运重建(体外循环组)或(ii)跳动心脏血运重建(非体外循环组)。连续测量肌钙蛋白I(Tn I)释放量作为心肌损伤的特异性标志物。还记录了血流动力学测量结果以及正性肌力药物需求、心律失常发生率和术后心肌梗死情况。
两组在年龄、性别、疾病程度、左心室功能和移植血管数量方面无显著差异。两组均无死亡或术中心肌梗死发生。非体外循环组的Tn I释放量始终较低,在术后1、4、12和24小时具有显著性差异。此外,该组心律失常的发生率显著降低。非体外循环组的正性肌力药物需求较少,但未达到统计学意义。
这些结果表明,非体外循环冠状动脉血运重建是一种安全有效的心肌血运重建策略。与采用CPB和心脏停搏的传统冠状动脉血运重建相比,通过Tn I释放评估的心肌损伤也有所减少。